Program subject to change.
8:30 - 9:30 | Workshops | ||||||
Workshop 1 Program to be announced | ||||||
Workshop 2 Program to be announced | ||||||
Workshop 3 Program to be announced | ||||||
9:30 - 11:00 | Concurrent Sessions | ||||||
Session A6: Pharmacoeconomics: economic aspects of pharmacotherapy Chairs: Miia Turpeinen, University of Oulu, Oulu, Finland and Dinko Vitezic, University of Rijeka, Rijeka, Croatia |
9:30 - 10:00 | Value based pricing of pharmaceuticals David Webb, University of Edinburgh, Edinburgh, United Kingdom | ||||
10:00 - 10:30 | Innovative cost-sharing models Zoltan Kalo, Semmelweis University, Budapest, Hungary | ||||
10:30 - 11:00 | Short oral presentations - To be announced | ||||
Session B8: Using routinely collected data to inform clinical pharmacology Chairs: Aleksi Tornio, University of Turku, Turku, Finland and Caridad Pontes, Universitat Autónoma de Barcelona, Barcelona, Spain | |||||
9:30 - 10:00 | Advances in pharmacoepidemiological analyses of real-world data Daniel Prieto-Alhambra, University of Oxford, Oxford, United Kingdom | ||||
10:00 - 10:30 | Strategic view on utilizing real-world data during drug development Susana Perez-Gutthann, RTI Health Solutions, Barcelona, Catalonia, Spain | ||||
10:30 - 11:00 | Short oral presentations - To be announced | ||||
Session C7: Global infectious disease threats Chairs: Asko Järvinen, Helsinki University Hospital, Helsinki, Finland and Markus Zeitlinger, Medical University of Vienna, Vienna, Austria | |||||
9:30 - 10:00 | New vaccine technologies as a response to Covid-19 and other infectious threats Hanna Nohynek, Chair, Strategic Advisory Group of Experts on Immunization (SAGE),WHO, Finland | ||||
10:00 - 10:30 | New drugs against multi-drug resistant (MDR) gram negative bacteria - are we loosing the battle against the silent pandemia Günther Weiss, Medical University of Innsbruck, Innsbruck, Austria | ||||
10:30 - 11:00 | Short oral presentations - To be announced | ||||
11:00 - 11:20 | Refreshment Break |
11:20 - 12:00 | Keynote Lecture 3 | |||||
Chair: Gerard Rongen, University of Nijmegen, Nijmegen, the Netherlands Topic to be announced Speaker to be announced | |||||
12:00 - 13:30 | Lunch and Poster Viewing | |||||
13:30 - 15:00 | Concurrent Sessions | |||||
ESPT & IUPHAR Session A7: Pharmacogenomics - challenges for implementation in different medical specialties Chairs: Mikko Niemi, University of Helsinki, Helsinki, Finland and Ann Daly, University of Newcastle, Newcastle, United Kingdom | |||||
13:30 - 14:00 | Implementing pharmacogenomics in psychiatry Elvira Bramon, University College London, London, United Kingdom | ||||
14:00 - 14:30 | Implementing pharmacogenomics in oncology Matthias Schwab, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany | ||||
14:30 - 15:00 | Short oral presentations - To be announced | ||||
Session B9: Advances in clinical trials methodology Chairs: Maija Kaukonen, Medbase, Helsinki, Finland and Florian Naudet, University of Rennes, Rennes, France | |||||
13:30 - 14:00 | Routinely collected data (previously named as Real-World Evidence, RWE) integration in clinical trials Lars G. Hemkens, University of Basel, Basel, Switzerland | ||||
14:00 - 14:30 | Innovative trial designs: Adaptive and platform trials Mireille Muller, Novartis, Basel, Switzerland | ||||
14:30 - 15:00 | Short oral presentations - To be announced | ||||
Session C8: New strategies in treatment of cancer Chairs: Olli Tenhunen, Finnish Medicines Agency Fimea and Oulu University Hospital, Oulu, Finland and Troels K. Bergmann, University of Southern Denmark, Odense, Denmark | |||||
13:30 - 14:00 | Repurposing of anti-cancer medicines Kimmo Porkka, University of Helsinki, Helsinki, Finland | ||||
14:00 - 14:30 | Topic to be announced - Speaker to be announced | ||||
14:30 - 15:00 | Short oral presentations - To be announced |
15:00 - 16:00 pm | Closing Session and Farewells | |||||
Awards and closing ceremony (EACPT Chairs) Poster/abstract presentation awards Greetings from EACPT Future Congresses | |||||